Stocksigma LogoStocksigma Logo

Fischer Medical Approves ₹50 Cr Capital Infusion Across Material Subsidiaries

Fischer Medical Ventures' board approved investments totaling ₹50.00 Cr in rights issues of three wholly owned material subsidiaries on 24th Sep'26

Fischer Medical Approves ₹50 Cr Capital Infusion Across Material Subsidiaries

Fischer Medical Ventures Ltd · Others (Uncategorized) · 24 Sept 2026, 11:33 pm

Fischer Medical Approves ₹50 Cr Capital Infusion Across Material Subsidiaries Fischer Medical Ventures' board approved investments totaling ₹50.00 Cr in rights issues of three wholly owned material subsidiaries on 24th Sep'26. The capital deployment includes ₹11.50 Cr for 15,603 shares in Time Medical International Ventures (India), ₹12.50 Cr for 1,507 shares in Flynncare Health Innovations, and ₹26.00 Cr for 53 shares in Singapore-based FMV Global Innovation Pte. Ltd. All transactions are all-cash subscriptions executed at arm's length based on registered valuer reports to support business growth across medical imaging, digital healthcare, and global diagnostics distribution.

Original exchange filing (PDF)

More announcements from Fischer Medical Ventures Ltd

All Fischer Medical Ventures Ltd announcements